Back
Aclaris Therapeutics Quote, Financials, Valuation and Earnings
My #1 Coin is...
All the details are on the next page.
Sell
11
ACRS
Aclaris Therapeutics
Last Price:
1.23
Seasonality Move:
-2.56%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.Aclaris Therapeutics Price Quote
$1.23
Aclaris Therapeutics Key Stats
Sell
11
Aclaris Therapeutics (ACRS)
is a Sell
Day range:
$1.21 - $1.25
52-week range:
$0.59 - $11.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.75
P/B ratio:
0.56%
Volume:
550.7K
Avg. volume:
877.5K
1-year change:
-87.15%
Market cap:
$87.2M
Revenue:
$31.2M
EPS:
$-1.27
How Much Does Aclaris Therapeutics Make?
-
How Much Are Aclaris Therapeutics's Sales Annually?
ACRS Revenues are $31.2M -
How Much Profit Does Aclaris Therapeutics's Make A Year?
ACRS net income is -$88.5M
Is Aclaris Therapeutics Growing As A Company?
-
What Is Aclaris Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.27% -
What Is Aclaris Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aclaris Therapeutics Stock Price Performance
-
Did Aclaris Therapeutics Stock Go Up Last Month?
Aclaris Therapeutics share price went up by 5.13% last month -
Did ACRS's Share Price Rise Over The Last Year?
ACRS share price fell by -87.15% over the past 1 year
What Is Aclaris Therapeutics 52-Week High & Low?
-
What Is Aclaris Therapeutics’s 52-Week High Share Price?
Aclaris Therapeutics has traded as high as $11.12 over the past 52 weeks -
What Is Aclaris Therapeutics’s 52-Week Low Share Price?
Aclaris Therapeutics has traded as low as $0.59 over the past 52 weeks
Aclaris Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aclaris Therapeutics?
-
How Much Debt Does Aclaris Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aclaris Therapeutics Have?
Cash and short term investments quarterly total is $119.1M -
What Is Aclaris Therapeutics’s Book Value Per Share?
Book value per share is 2.22
Is Aclaris Therapeutics Cash Flow Positive?
-
What Is ACRS Cash Flow From Operations?
Cash flow from operations (TTM) is -$78.3M -
What Is Aclaris Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.7M -
What Is Aclaris Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $46.2M
Aclaris Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ACRS return on invested capital is -50.99% -
What Is Aclaris Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -38.95% -
What Is ACRS Return On Equity?
ROE is a measure of profitability and is -50.99%
Aclaris Therapeutics Earnings Date & Stock Price
-
What Is Aclaris Therapeutics's Stock Price Today?
A single share of ACRS can be purchased today for 1.23 -
What Is Aclaris Therapeutics’s Stock Symbol?
Aclaris Therapeutics trades on the nasdaq under the ticker symbol: ACRS -
When Is Aclaris Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aclaris Therapeutics is scheduled on May 8, 2024 -
When Is ACRS's next ex-dividend date?
Aclaris Therapeutics's next ex-dividend date is April 18, 2024 -
How To Buy Aclaris Therapeutics Stock?
You can buy Aclaris Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aclaris Therapeutics Competitors
-
Who Are Aclaris Therapeutics's Competitors?
Below is a list of companies who compete with Aclaris Therapeutics or are related in some way:
Aclaris Therapeutics Dividend Yield
Data Unavailable
Aclaris Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 94.85% |
| Revenue: | 126.62% | 247.87% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 7 |
| Sell Recommendations: | 0 |
| Price Target: | 1.80 |
| Upside from Last Price: | 46.34% |